16/02/2026
Breast cancer is the most frequently diagnosed cancer in women worldwide and in Australia — over 20,000 diagnoses were projected in 2025 alone.
Approximately 70–80 % of all breast cancers are oestrogen ER + making it the most common subtype of breast cancer.
ER+ cancers are treated with approaches that either involve drugs that block the receptor or block the production of oestrogen.
When we significantly reduce or block oestrogen signalling, we are not only targeting tumour biology — we are altering a hormone that is a systemic regulatory molecule involved in regulating bone turnover, metabolic function, brain chemistry, vascular integrity, and genitourinary health.
When we suppress it, the body feels it -
Symptoms often include hot flushes, joint pain, mood changes, brain fog, vaginal dryness, loss of libido, recurrent UTIs.
These are not minor side effects!
We need to support women navigating cancer recovery, because without adequate support the burden can become isolating.
If you need support please book a free discovery call and enquire about my “Endocrine Management Therapy Programme” now!